25 XP   0   0   10

ChromaDex Corporation
Buy, Hold or Sell?

Let's analyse Chromadex together

PenkeI guess you are interested in ChromaDex Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ChromaDex Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about ChromaDex Corporation

I send you an email if I find something interesting about ChromaDex Corporation.

Quick analysis of Chromadex (30 sec.)










What can you expect buying and holding a share of Chromadex? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€0.35
Expected worth in 1 year
€0.35
How sure are you?
38.9%

+ What do you gain per year?

Total Gains per Share
€0.00
Return On Investment
-0.1%

For what price can you sell your share?

Current Price per Share
€3.12
Expected price per share
€2.055 - €4.06
How sure are you?
50%

1. Valuation of Chromadex (5 min.)




Live pricePrice per Share (EOD)

€3.12

Intrinsic Value Per Share

€-0.69 - €-0.77

Total Value Per Share

€-0.34 - €-0.42

2. Growth of Chromadex (5 min.)




Is Chromadex growing?

Current yearPrevious yearGrowGrow %
How rich?$28.4m$24m$3.6m13.1%

How much money is Chromadex making?

Current yearPrevious yearGrowGrow %
Making money-$1.2m-$4.1m$2.9m235.0%
Net Profit Margin-5.9%-23.9%--

How much money comes from the company's main activities?

3. Financial Health of Chromadex (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of Chromadex? (5 min.)

Welcome investor! Chromadex's management wants to use your money to grow the business. In return you get a share of Chromadex.

What can you expect buying and holding a share of Chromadex?

First you should know what it really means to hold a share of Chromadex. And how you can make/lose money.

Speculation

The Price per Share of Chromadex is €3.12. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Chromadex.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Chromadex, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.35. Based on the TTM, the Book Value Change Per Share is €0.00 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Chromadex.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.000.0%-0.02-0.6%-0.05-1.8%-0.06-2.0%-0.06-2.0%
Usd Book Value Change Per Share0.020.5%0.000.0%-0.01-0.3%0.020.7%0.020.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.020.5%0.000.0%-0.01-0.3%0.020.7%0.020.7%
Usd Price Per Share1.41-1.46-1.77-3.41-3.41-
Price to Earnings Ratio233.30-44.95--14.43--1.66--1.66-
Price-to-Total Gains Ratio92.67-114.37-92.65-4.39-4.39-
Price to Book Ratio3.74-3.96-5.56-9.71-9.71-
Price-to-Total Gains Ratio92.67-114.37-92.65-4.39-4.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.339024
Number of shares299
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.02
Usd Total Gains Per Share0.000.02
Gains per Quarter (299 shares)-0.216.28
Gains per Year (299 shares)-0.8625.11
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1-1102515
20-2-1205040
30-3-1307565
40-3-14010090
50-4-150126115
60-5-160151140
70-6-170176165
80-7-180201190
90-8-190226215
100-9-200251240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.017.00.05.6%1.017.00.05.6%1.017.00.05.6%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%7.011.00.038.9%7.011.00.038.9%7.011.00.038.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.018.00.0%0.00.018.00.0%0.00.018.00.0%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%7.011.00.038.9%7.011.00.038.9%7.011.00.038.9%

Fundamentals of Chromadex

About ChromaDex Corporation

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.

Fundamental data was last updated by Penke on 2024-04-08 03:29:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of ChromaDex Corporation.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Chromadex earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Chromadex to the Biotechnology industry mean.
  • A Net Profit Margin of 0.5% means that €0.01 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ChromaDex Corporation:

  • The MRQ is 0.5%. The company is not making a profit/loss.
  • The TTM is -5.9%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ0.5%TTM-5.9%+6.4%
TTM-5.9%YOY-23.9%+18.0%
TTM-5.9%5Y-30.2%+24.3%
5Y-30.2%10Y-30.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5%-207.2%+207.7%
TTM-5.9%-216.8%+210.9%
YOY-23.9%-282.3%+258.4%
5Y-30.2%-436.8%+406.6%
10Y-30.2%-597.3%+567.1%
1.1.2. Return on Assets

Shows how efficient Chromadex is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Chromadex to the Biotechnology industry mean.
  • 0.2% Return on Assets means that Chromadex generated €0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ChromaDex Corporation:

  • The MRQ is 0.2%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -2.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.2%TTM-2.3%+2.5%
TTM-2.3%YOY-8.3%+6.0%
TTM-2.3%5Y-9.8%+7.5%
5Y-9.8%10Y-9.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%-13.3%+13.5%
TTM-2.3%-12.8%+10.5%
YOY-8.3%-11.6%+3.3%
5Y-9.8%-13.8%+4.0%
10Y-9.8%-15.6%+5.8%
1.1.3. Return on Equity

Shows how efficient Chromadex is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Chromadex to the Biotechnology industry mean.
  • 0.4% Return on Equity means Chromadex generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ChromaDex Corporation:

  • The MRQ is 0.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -4.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.4%TTM-4.5%+4.9%
TTM-4.5%YOY-17.6%+13.1%
TTM-4.5%5Y-19.0%+14.5%
5Y-19.0%10Y-19.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4%-16.9%+17.3%
TTM-4.5%-16.1%+11.6%
YOY-17.6%-14.9%-2.7%
5Y-19.0%-19.3%+0.3%
10Y-19.0%-20.1%+1.1%

1.2. Operating Efficiency of ChromaDex Corporation.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Chromadex is operating .

  • Measures how much profit Chromadex makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Chromadex to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ChromaDex Corporation:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-2.8%+2.8%
TTM-2.8%YOY-27.0%+24.1%
TTM-2.8%5Y-30.0%+27.1%
5Y-30.0%10Y-30.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM-2.8%-238.5%+235.7%
YOY-27.0%-288.4%+261.4%
5Y-30.0%-486.2%+456.2%
10Y-30.0%-628.4%+598.4%
1.2.2. Operating Ratio

Measures how efficient Chromadex is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.40 means that the operating costs are €1.40 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of ChromaDex Corporation:

  • The MRQ is 1.398. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.459. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.398TTM1.459-0.062
TTM1.459YOY1.674-0.215
TTM1.4595Y1.710-0.251
5Y1.71010Y1.7100.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3983.235-1.837
TTM1.4593.310-1.851
YOY1.6743.838-2.164
5Y1.7105.679-3.969
10Y1.7107.823-6.113

1.3. Liquidity of ChromaDex Corporation.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Chromadex is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.40 means the company has €2.40 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of ChromaDex Corporation:

  • The MRQ is 2.402. The company is able to pay all its short-term debts. +1
  • The TTM is 2.447. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.402TTM2.447-0.045
TTM2.447YOY2.357+0.091
TTM2.4475Y2.546-0.098
5Y2.54610Y2.5460.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4023.863-1.461
TTM2.4474.169-1.722
YOY2.3575.337-2.980
5Y2.5466.122-3.576
10Y2.5466.434-3.888
1.3.2. Quick Ratio

Measures if Chromadex is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Chromadex to the Biotechnology industry mean.
  • A Quick Ratio of 0.25 means the company can pay off €0.25 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ChromaDex Corporation:

  • The MRQ is 0.254. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.341. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.254TTM0.341-0.087
TTM0.341YOY0.359-0.018
TTM0.3415Y0.310+0.031
5Y0.31010Y0.3100.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2543.504-3.250
TTM0.3413.991-3.650
YOY0.3595.371-5.012
5Y0.3106.088-5.778
10Y0.3106.395-6.085

1.4. Solvency of ChromaDex Corporation.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Chromadex assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Chromadex to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.48 means that Chromadex assets are financed with 48.2% credit (debt) and the remaining percentage (100% - 48.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ChromaDex Corporation:

  • The MRQ is 0.482. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.485. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.482TTM0.485-0.003
TTM0.485YOY0.519-0.034
TTM0.4855Y0.474+0.011
5Y0.47410Y0.4740.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4820.339+0.143
TTM0.4850.337+0.148
YOY0.5190.271+0.248
5Y0.4740.368+0.106
10Y0.4740.388+0.086
1.4.2. Debt to Equity Ratio

Measures if Chromadex is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Chromadex to the Biotechnology industry mean.
  • A Debt to Equity ratio of 93.2% means that company has €0.93 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ChromaDex Corporation:

  • The MRQ is 0.932. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.942. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.932TTM0.942-0.010
TTM0.942YOY1.087-0.145
TTM0.9425Y0.927+0.015
5Y0.92710Y0.9270.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9320.392+0.540
TTM0.9420.403+0.539
YOY1.0870.335+0.752
5Y0.9270.427+0.500
10Y0.9270.461+0.466

2. Market Valuation of ChromaDex Corporation

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Chromadex generates.

  • Above 15 is considered overpriced but always compare Chromadex to the Biotechnology industry mean.
  • A PE ratio of 233.30 means the investor is paying €233.30 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ChromaDex Corporation:

  • The EOD is 551.448. Based on the earnings, the company is expensive. -2
  • The MRQ is 233.305. Based on the earnings, the company is expensive. -2
  • The TTM is 44.955. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD551.448MRQ233.305+318.143
MRQ233.305TTM44.955+188.350
TTM44.955YOY-14.432+59.387
TTM44.9555Y-1.660+46.615
5Y-1.66010Y-1.6600.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD551.448-2.300+553.748
MRQ233.305-2.656+235.961
TTM44.955-2.718+47.673
YOY-14.432-4.145-10.287
5Y-1.660-6.258+4.598
10Y-1.660-6.315+4.655
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ChromaDex Corporation:

  • The EOD is 100.104. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 42.352. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 33.131. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD100.104MRQ42.352+57.752
MRQ42.352TTM33.131+9.221
TTM33.131YOY-20.338+53.469
TTM33.1315Y90.809-57.678
5Y90.80910Y90.8090.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD100.104-2.974+103.078
MRQ42.352-3.306+45.658
TTM33.131-3.508+36.639
YOY-20.338-5.613-14.725
5Y90.809-8.378+99.187
10Y90.809-8.873+99.682
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Chromadex is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.74 means the investor is paying €3.74 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of ChromaDex Corporation:

  • The EOD is 8.837. Based on the equity, the company is overpriced. -1
  • The MRQ is 3.739. Based on the equity, the company is fair priced.
  • The TTM is 3.965. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD8.837MRQ3.739+5.098
MRQ3.739TTM3.965-0.226
TTM3.965YOY5.564-1.599
TTM3.9655Y9.712-5.747
5Y9.71210Y9.7120.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD8.8371.914+6.923
MRQ3.7392.116+1.623
TTM3.9652.097+1.868
YOY5.5642.881+2.683
5Y9.7123.550+6.162
10Y9.7123.936+5.776
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ChromaDex Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.014-0.001+105%-0.009+167%0.020-27%0.020-27%
Book Value Per Share--0.3530.344+3%0.299+18%0.332+6%0.332+6%
Current Ratio--2.4022.447-2%2.357+2%2.546-6%2.546-6%
Debt To Asset Ratio--0.4820.485-1%0.519-7%0.474+2%0.474+2%
Debt To Equity Ratio--0.9320.942-1%1.087-14%0.927+0%0.927+0%
Dividend Per Share----0%-0%-0%-0%
Eps--0.001-0.016+1246%-0.051+3727%-0.059+4236%-0.059+4236%
Free Cash Flow Per Share--0.0080.022-64%-0.048+714%-0.034+535%-0.034+535%
Free Cash Flow To Equity Per Share--0.0070.022-68%-0.024+452%0.007+3%0.007+3%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.769--------
Intrinsic Value_10Y_min---0.688--------
Intrinsic Value_1Y_max---0.128--------
Intrinsic Value_1Y_min---0.126--------
Intrinsic Value_3Y_max---0.345--------
Intrinsic Value_3Y_min---0.331--------
Intrinsic Value_5Y_max---0.516--------
Intrinsic Value_5Y_min---0.483--------
Market Cap234964404.480+58%99408017.280102665136.028-3%124420053.446-20%239740256.825-59%239740256.825-59%
Net Profit Margin--0.005-0.059+1197%-0.239+4544%-0.302+5720%-0.302+5720%
Operating Margin----0.0280%-0.2700%-0.3000%-0.3000%
Operating Ratio--1.3981.459-4%1.674-17%1.710-18%1.710-18%
Pb Ratio8.837+58%3.7393.965-6%5.564-33%9.712-62%9.712-62%
Pe Ratio551.448+58%233.30544.955+419%-14.432+106%-1.660+101%-1.660+101%
Price Per Share3.120+58%1.3201.363-3%1.652-20%3.183-59%3.183-59%
Price To Free Cash Flow Ratio100.104+58%42.35233.131+28%-20.338+148%90.809-53%90.809-53%
Price To Total Gains Ratio219.042+58%92.672114.368-19%92.646+0%4.392+2010%4.392+2010%
Quick Ratio--0.2540.341-26%0.359-29%0.310-18%0.310-18%
Return On Assets--0.002-0.023+1214%-0.083+4093%-0.098+4831%-0.098+4831%
Return On Equity--0.004-0.045+1221%-0.176+4489%-0.190+4837%-0.190+4837%
Total Gains Per Share--0.014-0.001+105%-0.009+167%0.020-27%0.020-27%
Usd Book Value--28455854.30527732608.008+3%24087376.672+18%26780862.881+6%26780862.881+6%
Usd Book Value Change Per Share--0.015-0.001+105%-0.010+167%0.021-27%0.021-27%
Usd Book Value Per Share--0.3780.368+3%0.320+18%0.356+6%0.356+6%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.002-0.017+1246%-0.055+3727%-0.063+4236%-0.063+4236%
Usd Free Cash Flow--627996.7851764990.963-64%-3857980.247+714%-2426987.574+486%-2426987.574+486%
Usd Free Cash Flow Per Share--0.0080.023-64%-0.051+714%-0.036+535%-0.036+535%
Usd Free Cash Flow To Equity Per Share--0.0070.023-68%-0.026+452%0.007+3%0.007+3%
Usd Market Cap251458905.674+58%106386460.093109872228.577-3%133154341.198-20%256570022.854-59%256570022.854-59%
Usd Price Per Share3.339+58%1.4131.459-3%1.768-20%3.407-59%3.407-59%
Usd Profit--113999.416-1234493.679+1183%-4134978.829+3727%-4699198.162+4222%-4699198.162+4222%
Usd Revenue--21195891.47620892393.030+1%18012407.776+18%17081468.098+24%17081468.098+24%
Usd Total Gains Per Share--0.015-0.001+105%-0.010+167%0.021-27%0.021-27%
 EOD+4 -4MRQTTM+19 -13YOY+26 -65Y+20 -1210Y+20 -12

3.2. Fundamental Score

Let's check the fundamental score of ChromaDex Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15551.448
Price to Book Ratio (EOD)Between0-18.837
Net Profit Margin (MRQ)Greater than00.005
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.254
Current Ratio (MRQ)Greater than12.402
Debt to Asset Ratio (MRQ)Less than10.482
Debt to Equity Ratio (MRQ)Less than10.932
Return on Equity (MRQ)Greater than0.150.004
Return on Assets (MRQ)Greater than0.050.002
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of ChromaDex Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose3.120
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income before Tax  -1,325-452-1,777-270-2,0471,151-8961,003107
Net Income  -1,325-452-1,777-270-2,0471,151-8961,003107
Net Income from Continuing Operations  -1,325-452-1,777-270-2,0471,151-8961,003107



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets54,964
Total Liabilities26,508
Total Stockholder Equity28,456
 As reported
Total Liabilities 26,508
Total Stockholder Equity+ 28,456
Total Assets = 54,964

Assets

Total Assets54,964
Total Current Assets49,534
Long-term Assets5,430
Total Current Assets
Cash And Cash Equivalents 27,173
Net Receivables 5,234
Inventory 14,525
Other Current Assets 2,450
Total Current Assets  (as reported)49,534
Total Current Assets  (calculated)49,382
+/- 152
Long-term Assets
Property Plant Equipment 4,537
Intangible Assets 510
Long-term Assets Other 383
Long-term Assets  (as reported)5,430
Long-term Assets  (calculated)5,430
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities20,622
Long-term Liabilities5,886
Total Stockholder Equity28,456
Total Current Liabilities
Accounts payable 10,232
Total Current Liabilities  (as reported)20,622
Total Current Liabilities  (calculated)10,232
+/- 10,390
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt3,277
Long-term Liabilities  (as reported)5,886
Long-term Liabilities  (calculated)3,277
+/- 2,609
Total Stockholder Equity
Total Stockholder Equity (as reported)28,456
Total Stockholder Equity (calculated)0
+/- 28,456
Other
Capital Stock75
Common Stock Shares Outstanding 74,981
Net Invested Capital 28,456
Net Working Capital 28,912
Property Plant and Equipment Gross 9,947



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
43,139
40,247
35,610
41,992
37,415
38,358
68,993
65,842
60,452
57,840
52,930
46,613
45,665
54,057
53,768
53,171
53,483
54,964
54,96453,48353,17153,76854,05745,66546,61352,93057,84060,45265,84268,99338,35837,41541,99235,61040,24743,139
   > Total Current Assets 
36,365
33,518
29,147
35,766
30,728
32,219
63,219
57,932
52,835
48,905
44,523
38,508
37,901
46,567
46,565
46,382
47,181
49,534
49,53447,18146,38246,56546,56737,90138,50844,52348,90552,83557,93263,21932,21930,72835,76629,14733,51836,365
       Cash And Cash Equivalents 
18,679
18,612
13,408
18,690
15,278
16,497
44,491
38,578
32,902
28,019
20,793
16,872
13,062
20,241
22,989
26,254
26,621
27,173
27,17326,62126,25422,98920,24113,06216,87220,79328,01932,90238,57844,49116,49715,27818,69013,40818,61218,679
       Net Receivables 
5,953
2,175
3,558
3,954
3,214
2,694
4,647
5,999
5,295
5,226
6,310
4,228
4,744
10,282
9,221
6,118
5,601
5,234
5,2345,6016,1189,22110,2824,7444,2286,3105,2265,2955,9994,6472,6943,2143,9543,5582,1755,953
       Inventory 
9,820
11,535
11,280
12,338
11,031
11,683
12,762
12,183
12,676
13,601
15,307
15,753
15,636
14,677
11,908
11,973
12,624
14,525
14,52512,62411,97311,90814,67715,63615,75315,30713,60112,67612,18312,76211,68311,03112,33811,28011,5359,820
   > Long-term Assets 
6,774
6,729
6,463
6,226
6,687
6,139
5,774
7,910
7,617
8,935
8,407
8,105
7,764
7,490
7,203
6,789
6,302
5,430
5,4306,3026,7897,2037,4907,7648,1058,4078,9357,6177,9105,7746,1396,6876,2266,4636,7296,774
       Property Plant Equipment 
0
4,656
4,412
4,192
4,630
4,432
4,158
6,332
6,133
7,355
6,993
6,783
6,505
6,322
6,041
5,680
5,296
4,537
4,5375,2965,6806,0416,3226,5056,7836,9937,3556,1336,3324,1584,4324,6304,1924,4124,6560
       Intangible Assets 
1,373
1,311
1,249
1,189
0
1,082
1,022
961
908
857
808
758
714
671
630
591
552
510
5105525916306717147588088579089611,0221,08201,1891,2491,3111,373
       Long-term Assets Other 
660
762
802
845
910
625
594
617
576
723
606
564
545
497
532
518
454
383
383454518532497545564606723576617594625910845802762660
> Total Liabilities 
15,997
19,802
19,062
20,411
17,928
21,934
25,161
23,700
25,003
26,113
27,053
25,835
24,642
25,385
25,751
26,021
26,175
26,508
26,50826,17526,02125,75125,38524,64225,83527,05326,11325,00323,70025,16121,93417,92820,41119,06219,80215,997
   > Total Current Liabilities 
11,023
15,063
14,466
16,042
13,015
16,476
19,756
16,229
17,770
17,613
18,694
17,725
16,727
17,869
18,423
19,061
19,444
20,622
20,62219,44419,06118,42317,86916,72717,72518,69417,61317,77016,22919,75616,47613,01516,04214,46615,06311,023
       Accounts payable 
6,168
9,626
8,159
9,780
6,881
9,445
11,693
9,970
10,804
10,423
9,780
10,197
9,119
9,679
8,951
10,031
9,198
10,232
10,2329,19810,0318,9519,6799,11910,1979,78010,42310,8049,97011,6939,4456,8819,7808,1599,6266,168
       Other Current Liabilities 
0
169
238
250
228
278
231
210
175
161
141
173
158
157
0
166
0
0
0016601571581731411611752102312782282502381690
   > Long-term Liabilities 
4,974
4,739
4,596
4,369
4,913
5,458
5,405
7,471
7,233
8,500
8,359
8,110
7,915
7,516
7,328
6,960
6,731
5,886
5,8866,7316,9607,3287,5167,9158,1108,3598,5007,2337,4715,4055,4584,9134,3694,5964,7394,974
       Capital Lease Obligations Min Short Term Debt
2,002
1,719
1,543
1,315
1,826
1,637
1,468
3,510
3,347
4,702
4,660
4,541
4,381
4,257
4,087
3,939
3,789
3,277
3,2773,7893,9394,0874,2574,3814,5414,6604,7023,3473,5101,4681,6371,8261,3151,5431,7192,002
       Other Liabilities 
0
3,873
3,873
3,820
3,820
4,441
4,441
4,441
4,346
4,346
4,346
4,228
4,228
3,955
0
3,806
0
0
003,80603,9554,2284,2284,3464,3464,3464,4414,4414,4413,8203,8203,8733,8730
> Total Stockholder Equity
27,142
20,445
16,548
21,581
19,487
16,424
43,832
42,142
35,449
31,727
25,877
20,778
21,023
28,672
28,017
27,150
27,308
28,456
28,45627,30827,15028,01728,67221,02320,77825,87731,72735,44942,14243,83216,42419,48721,58116,54820,44527,142
   Common Stock
0
60
60
61
62
62
68
68
68
68
68
68
68
74
0
75
0
0
00750746868686868686862626160600
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
0
0
-3
-3
-3
-2
-2
-2
-2
0
2
3
-3
0
-1
0
0
00-10-3320-2-2-2-2-3-3-3000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue83,570
Cost of Revenue-32,790
Gross Profit50,78050,780
 
Operating Income (+$)
Gross Profit50,780
Operating Expense-89,169
Operating Income-5,599-38,389
 
Operating Expense (+$)
Research Development4,958
Selling General Administrative51,421
Selling And Marketing Expenses-
Operating Expense89,16956,379
 
Net Interest Income (+$)
Interest Income661
Interest Expense--
Other Finance Cost-0
Net Interest Income661
 
Pretax Income (+$)
Operating Income-5,599
Net Interest Income661
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-4,938-5,599
EBIT - interestExpense = 0
-4,938
-4,938
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--4,938
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-4,938
Tax Provision--
Net Income From Continuing Ops-4,938-4,938
Net Income-4,938
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--661
 

Technical Analysis of Chromadex
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Chromadex. The general trend of Chromadex is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Chromadex's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ChromaDex Corporation.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.06.

The bearish price targets are: 2.139 > 2.123 > 2.055.

Tweet this
ChromaDex Corporation Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ChromaDex Corporation. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ChromaDex Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ChromaDex Corporation.

ChromaDex Corporation Daily Moving Average Convergence/Divergence (MACD) ChartChromaDex Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ChromaDex Corporation. The current adx is .

ChromaDex Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ChromaDex Corporation.

ChromaDex Corporation Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ChromaDex Corporation.

ChromaDex Corporation Daily Relative Strength Index (RSI) ChartChromaDex Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ChromaDex Corporation.

ChromaDex Corporation Daily Stochastic Oscillator ChartChromaDex Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ChromaDex Corporation.

ChromaDex Corporation Daily Commodity Channel Index (CCI) ChartChromaDex Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ChromaDex Corporation.

ChromaDex Corporation Daily Chande Momentum Oscillator (CMO) ChartChromaDex Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ChromaDex Corporation.

ChromaDex Corporation Daily Williams %R ChartChromaDex Corporation Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ChromaDex Corporation.

ChromaDex Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ChromaDex Corporation.

ChromaDex Corporation Daily Average True Range (ATR) ChartChromaDex Corporation Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ChromaDex Corporation.

ChromaDex Corporation Daily On-Balance Volume (OBV) ChartChromaDex Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ChromaDex Corporation.

ChromaDex Corporation Daily Money Flow Index (MFI) ChartChromaDex Corporation Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ChromaDex Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-08 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-19 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-12 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-22 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-27 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-05 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-15 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-23 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-24 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

ChromaDex Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ChromaDex Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose3.120
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Chromadex with someone you think should read this too:
  • Are you bullish or bearish on Chromadex? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Chromadex? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ChromaDex Corporation

I send you an email if I find something interesting about ChromaDex Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about ChromaDex Corporation.

Receive notifications about ChromaDex Corporation in your mailbox!